FDA Import Refusal 799-0082108-4/21/1 — ELI LILLY CANADA INC
The FDA refused shipment 799-0082108-4/21/1 from ELI LILLY CANADA INC (Canada) on Apr 5, 2024. The refused product falls under Drugs and Biologics — LISPRO INSULIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Apr 5, 2024
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCP54 LISPRO INSULIN (ANTI-DIABETIC)
- Charges
- 75